Tumor-associated macrophages in immunotherapy.

Shijia Yan1, Guohui Wan1

  • 1National-Local Joint Engineering Laboratory of Druggability and New Drug Evaluation, National Engineering Research Center for New Drug and Druggability (Cultivation), Guangdong Province Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.

The FEBS Journal
|January 25, 2021
PubMed
Summary

Tumor-associated macrophages (TAMs) are key players in cancer progression and metastasis. Understanding TAM heterogeneity and function is crucial for developing effective cancer immunotherapies and overcoming treatment resistance.

Related Concept Videos